Physiology & Behavior, Journal Year: 2024, Volume and Issue: 291, P. 114782 - 114782
Published: Dec. 12, 2024
Language: Английский
Physiology & Behavior, Journal Year: 2024, Volume and Issue: 291, P. 114782 - 114782
Published: Dec. 12, 2024
Language: Английский
Heliyon, Journal Year: 2024, Volume and Issue: 10(7), P. e28610 - e28610
Published: March 28, 2024
In Africa, there is currently a paucity of data on the epidemiology depression, its treatment and management. The prevalence depression severely underestimated, with unique circumstances societal risk factors associated public awareness. Treating managing confounded by an inaccessibility to efficient low-cost treatments for patients depression. aetiology multifactorial, various theories implicating multiple neuronal networks. Despite this, one-dimensional focussing outdated mainly targeting dysfunctional neurotransmitter pathways. Hence, it not surprising that significant increase in suffering from resistant (TRD), large portion deriving little clinical benefit these traditional anti-depressant therapies. This highlights need more effective strategies especially applicable resource limited environments such as where investment healthcare resources towards mental health disorders. potential using ketamine has received considerable attention past two decades, FDA approving esketamine management TRD 2019. widespread significantly increased ketamine's appeal novel antidepressant. Consequently, many infusion clinics have been established Africa. However, regulation or guidance infusions. Furthermore, while expensive hence inaccessible African population, racemic cheaper demonstrated potential. understanding neurological mechanisms action treating diverse population. Therefore, this review aims provide context therapeutic highlighting aspects molecular mechanism action.
Language: Английский
Citations
1Psychopharmacology, Journal Year: 2024, Volume and Issue: unknown
Published: Aug. 22, 2024
Previous studies have reported conflicting findings regarding the efficacy of esketamine in managing postoperative depression. While positive effects subanesthetic doses been observed treatment-resistant depression, response to this medication patients experiencing depression following surgery has not consistent. Building upon known impact anesthesia on brain function, we formulated a hypothesis suggesting that timing administration relation may significantly affect its The aim study was investigate effect administered at different time points before and after anesthesia.
Language: Английский
Citations
1Pharmacology Biochemistry and Behavior, Journal Year: 2024, Volume and Issue: unknown, P. 173901 - 173901
Published: Oct. 1, 2024
Language: Английский
Citations
0Physiology & Behavior, Journal Year: 2024, Volume and Issue: 291, P. 114782 - 114782
Published: Dec. 12, 2024
Language: Английский
Citations
0